Nymox Pharmaceutical
NYMX
#10801
Rank
โ‚ฌ16.32 M
Marketcap
Country
0,18ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.12 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ5.84 Million, an increase over its 2021 earnings that were of -โ‚ฌ11.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.12 Million-63.78%
2022 -โ‚ฌ5.84 Million-47.71%
2021 -โ‚ฌ11.17 Million6.61%
2020 -โ‚ฌ10.47 Million-10.91%
2019 -โ‚ฌ11.76 Million24.24%
2018 -โ‚ฌ9.46 Million-20.03%
2017 -โ‚ฌ11.83 Million2.71%
2016 -โ‚ฌ11.52 Million-63.86%
2015 -โ‚ฌ31.87 Million674.44%
2014 -โ‚ฌ4.12 Million-6.11%
2013 -โ‚ฌ4.39 Million-35.66%
2012 -โ‚ฌ6.82 Million-20.76%
2011 -โ‚ฌ8.6 Million38.33%
2010 -โ‚ฌ6.22 Million35.59%
2009 -โ‚ฌ4.59 Million11.8%
2008 -โ‚ฌ4.1 Million-12.94%
2007 -โ‚ฌ4.71 Million8.85%
2006 -โ‚ฌ4.33 Million36.5%
2005 -โ‚ฌ3.17 Million-4.4%
2004 -โ‚ฌ3.32 Million-14.58%
2003 -โ‚ฌ3.89 Million
2001 -โ‚ฌ2.85 Million-20.54%
2000 -โ‚ฌ3.59 Million21.72%
1999 -โ‚ฌ2.95 Million-25.56%
1998 -โ‚ฌ3.96 Million101.3%
1997 -โ‚ฌ1.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.43 B-1,212,871.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.17 B-319,720.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.27 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ30.04 B-1,554,732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.25 B-65,069.92%๐Ÿ‡บ๐Ÿ‡ธ USA